Scholars Central

Conference abstractPublished 18 Nov 2014

Shedding of prion protein through modulation of ADAM10 activity reduces the binding and neurotoxicity of Aβ oligomers

Authors: Heledd H Griffiths

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The cellular prion protein (PrPC) is ahigh-affinity neuronal receptorfor amyloid-β (Aβ) oligomers, mediating neuronal impairment via the activation of Fyn kinase and phosphorylation of tau. The β-secretase, ADAM10, which cleaves the amyloid precursor protein (APP) releasing the neuroprotectives APPβ and precluding the formation of Aβ, also sheds PrPC from the cell surface. It is hypothesised that modulation of the shedding of PrPC by ADAM10 would alter the binding and neurotoxicity of Aβ oligomers. SH-SY5Y cells were treated with siRNA targeted against ADAM10 or with pharmacological agents (e.g. carbachol, resveratrol) to reduce or activate ADAM10 activity, respectively. siRNA knockdown of ADAM10 resulted in increased full length PrPC at the cell surface and increased the amount of Aβ oligomers bound to the cells. Antibody blocking of the Aβoligomer binding site on PrPC prevented the increase in binding observed following ADAM10 siRNA. Conversely, up-regulation of ADAM10 activity promoted the shedding of PrPC from the cell surface, and consequently reduced the binding of Aβ oligomers to cells. The specificity of each activator for ADAM10 was tested by monitoring sAPPα production following siRNA knockdown of ADAM10. Carbachol modulates ADAM10 activity, but also modulates sAPPα production via a different pathway, whereas resveratrol solely modulates sAPPα production via ADAM10. Developing specific agonists of ADAM10 will not only preclude Aβ formation and up-regulate neuroprotectives APPα, but it will also prevent the binding of soluble Aβ oligomers to PrPC and prevent the aberrant activation of signaling pathways which lead to neurotoxicity.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Heledd H Griffiths”